Global home infusion therapy market

Home Infusion Therapy Market Size, Share, Growth Analysis, By Indication Analysis(Enteral Nutrition, Anti-Infective, Chemotherapy, Parenteral Nutrition), By Product Analysis(Devices, Drugs, Services), By Region - Industry Forecast 2024-2031


Report ID: SQSG35J2007 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 67 | Figures: 75

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Home Infusion Therapy Market size was valued at USD 43.35 billion in 2019 and is poised to grow from USD 45.41 billion in 2023 to USD 65.2 billion by 2031, growing at a CAGR of 4.63% in the forecast period (2024-2031).

The competitive landscape of the global home infusion therapy market outlook is characterized by the presence of numerous established players and emerging companies focusing on innovative solutions. Some of the major foreign players are Baxter International, B. Braun Melsungen AG, Smiths Medical, and Fresenius Kabi. These companies are continually working to create new infusion devices which enhance the safety and comfort of patients, while also widening their range of products. Strategic alliances and technological developments are among the key drivers of competition and market growth in this dynamic sector. 'B. Braun Melsungen AG', 'Baxter International Inc.', 'Fresenius Kabi AG', 'ICU Medical, Inc.', 'Smiths Medical, Inc.', 'CareFusion Corporation', 'Terumo Corporation', 'Caesarea Medical Electronics Ltd.', 'JMS Co., Ltd.', 'Eli Lilly and Company', 'Pfizer Inc.', 'Novartis AG', 'Johnson & Johnson', 'Becton, Dickinson and Company', 'Roche Holding AG', 'Cigna Corporation', 'Optum, Inc.', 'Medtronic Plc', '3M Company', 'Omnicell, Inc.'

The rising prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, is a significant driver of the global home infusion therapy market size. With the increasing number of people needing chronic care and medication, home infusion therapy is one of the simplest and most effective options that reduce hospital visits and increase comfort levels of patients. 

Shift Towards Patient-Centric Care: The global home infusion therapy market trends will soon evolve to emphasize patient-centered care by increasing patient-specific treatment plans. This trend is influenced by the increasing desire for ease and comfort thus enabling patients to control chronic diseases from the home setting with minimal hospital visits and lower care costs. 

The global home infusion therapy market is largely dominated by North America due to a number of reasons such as the presence of developed healthcare systems, high technological adoption rates and an increase in the population that is elderly and suffers from chronic medical illnesses that need continuous care. New devices such as smart pumps and continuous glucose monitors that have emerged into the market are helping improve patient compliance and also assist in management of blood sugar levels. In fact, self-management and cost-effective care are on the rise leading to the need for better home infusion therapies for the patients. North America’s home infusion therapy market share is fueled by the presence of key market players and continuous infusion technology advancements. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global home infusion therapy market

Report ID: SQSG35J2007

$5,300
BUY NOW GET FREE SAMPLE